Swiss pharma giant Novartis was trading 3% higher on Tuesday afternoon after presenting its first-quarter financial results and latest full-year guidance. 25 April 2023
Research from industry analyst GlobalData highlights the significance of the pediatric treatment opportunity for Novartis’ Entresto (sacubitril/valsartan). 18 April 2023
Karim Mikhail is to resign as president and chief executive of Amarin Corp, the Ireland-headquartered fish oil-based heart drug specialist, according to a US Se 3 April 2023
German generics drugmaker STADA Arzneimittel has reported an 11% growth in sales in its annual results statement, propelled by “numerous launches and line exten 6 March 2023
While Esperion announced a statistically significant outcome for heart med Nexletol (bempedoic acid) over the weekend, markets were less than impressed with the 6 March 2023
Werner Baumann, chairman of the board of management at the German life sciences major Bayer, presented his final set of annual financial results on Tuesday. 28 February 2023
When new group chief executive Bill Anderson takes over at Bayer (BAYN: DE) in June, he will find a Pharmaceuticals Division that looks very different to the or 13 February 2023
Britain’s AstraZeneca has secured a new European approval for heart med Forxiga (dapagliflozin), an innovative medicine known in the USA as Farxiga. 8 February 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.